Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults

Clinical trial NCT00772109 · COMPLETED

Trial details

NCT number: NCT00772109
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Orthomyxoviridae Infection Influenza Myxovirus Infection

Start date: 2008-10-01
Primary completion: 2009-05-01
Enrollment: 4292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.